Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Tuberculosis (TB)








Reported Tuberculosis in the United States, 2021						Print
																Related Pages
										Return to Main Menu
Table 34. Tuberculosis Cases and Incidence Rates per 100,000 Population: Reporting Areas, 2021 and 2020
See Surveillance Slides #6, #7, #8, and #9.
Tuberculosis cases and incidence rates by reporting area.
Reporting area
Cases
Incidence rates
Population estimates2021
2020
Percentage change
2021
2020
Percentage change
July 1, 2021United States1
7,882
7,171
9.9
2.4
2.2
9.8
331,893,745Alabama
92
72
27.8
1.8
1.4
27.4
5,039,877Alaska
58
58
0.0
7.9
7.9
0.0
732,673Arizona
129
136
-5.1
1.8
1.9
-6.4
7,276,316Arkansas
69
59
16.9
2.3
2.0
16.4
3,025,891California
1,752
1,704
2.8
4.5
4.3
3.5
39,237,836Colorado
58
52
11.5
1.0
0.9
11.0
5,812,069Connecticut
54
54
0.0
1.5
1.5
-0.1
3,605,597Delaware
41
17
141.2
4.1
1.7
138.4
1,003,384District of Columbia
18
19
-5.3
2.7
2.8
-2.4
670,050Florida
500
412
21.4
2.3
1.9
20.2
21,781,128Georgia
223
221
0.9
2.1
2.1
0.2
10,799,566Hawaii
106
92
15.2
7.4
6.3
16.0
1,441,553Idaho
5
8
-37.5
0.3
0.4
-39.2
1,900,923Illinois
254
216
17.6
2.0
1.7
18.6
12,671,469Indiana
127
92
38.0
1.9
1.4
37.6
6,805,985Iowa
49
39
25.6
1.5
1.2
25.5
3,193,079Kansas
43
37
16.2
1.5
1.3
16.3
2,934,582Kentucky
57
66
-13.6
1.3
1.5
-13.7
4,509,394Louisiana
86
99
-13.1
1.9
2.1
-12.6
4,624,047Maine
14
17
-17.6
1.0
1.2
-18.2
1,372,247Maryland
195
148
31.8
3.2
2.4
31.9
6,165,129Massachusetts
151
142
6.3
2.2
2.0
6.9
6,984,723Michigan
137
101
35.6
1.4
1.0
35.9
10,050,811Minnesota
134
117
14.5
2.3
2.1
14.5
5,707,390Mississippi
46
43
7.0
1.6
1.5
7.2
2,949,965Missouri
78
79
-1.3
1.3
1.3
-1.5
6,168,187Montana
3
4
-25.0
0.3
0.4
-26.2
1,104,271Nebraska
22
33
-33.3
1.1
1.7
-33.4
1,963,692Nevada
61
57
7.0
1.9
1.8
6.0
3,143,991New Hampshire
12
12
0.0
0.9
0.9
-0.8
1,388,992New Jersey
292
245
19.2
3.2
2.6
19.3
9,267,130New Mexico
24
29
-17.2
1.1
1.4
-17.2
2,115,877New York State2
154
161
-4.3
1.4
1.4
-4.2
11,368,400New York City
529
444
19.1
6.2
5.1
23.4
8,467,513North Carolina
178
159
11.9
1.7
1.5
11.0
10,551,162North Dakota
15
10
50.0
1.9
1.3
50.8
774,948Ohio
150
130
15.4
1.3
1.1
15.5
11,780,017Oklahoma
69
67
3.0
1.7
1.7
2.3
3,986,639Oregon
76
67
13.4
1.8
1.6
13.3
4,246,155Pennsylvania
166
157
5.7
1.3
1.2
5.9
12,964,056Rhode Island
17
7
142.9
1.6
0.6
143.0
1,095,610South Carolina
87
67
29.9
1.7
1.3
28.4
5,190,705South Dakota
12
16
-25.0
1.3
1.8
-25.7
895,376Tennessee
84
113
-25.7
1.2
1.6
-26.3
6,975,218Texas
1,000
881
13.5
3.4
3.0
12.3
29,527,941Utah
17
29
-41.4
0.5
0.9
-42.4
3,337,975Vermont
3
3
0.0
0.5
0.5
-0.5
645,570Virginia
161
169
-4.7
1.9
2.0
-4.8
8,642,274Washington
199
163
22.1
2.6
2.1
21.8
7,738,692West Virginia
6
13
-53.8
0.3
0.7
-53.7
1,782,959Wisconsin
66
35
88.6
1.1
0.6
88.5
5,895,908Wyoming
3
0
...
0.5
0.0
...
578,803American Samoa
4
3
33.3
8.6
6.3
36.3
46,366Federated States of Micronesia
71
84
-15.5
62.8
74.9
-16.2
113,131Guam
58
57
1.8
34.4
33.8
1.6
168,801Republic of the Marshall Islands
118
149
-20.8
280.6
343.2
-18.2
42,050Northern Mariana Islands
35
38
-7.9
67.8
73.3
-7.6
51,659Puerto Rico
18
27
-33.3
0.6
0.8
-33.0
3,263,584Republic of Palau
6
9
-33.3
33.3
50.1
-33.5
18,024U.S. Virgin Islands
2
4
-50.0
1.9
3.8
-49.8
105,8701American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands are not included in the U.S. totals and percentages.2Excludes New York City.
**Note:**
Denominators for computing 2020 and 2021 incidence rates for states, the District of Columbia, and Puerto Rico were obtained from U.S. Census Annual Estimates of the Resident Population for the United States, Regions, States, the District of Columbia and Puerto Rico (April 1, 2020 to July 1, 2021).
Totals for U.S. territories (excluding Puerto Rico) were obtained from the International Data Base and totals for freely associated states were obtained from the United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019, Online Edition. Total Population (both sexes combined) by region, subregion and country, annually for 1950-2100 (thousands) Estimates, 1950 – 2020; accessed July 13, 2022.”
Ellipses (...) indicate that the percentage cannot be calculated, and the denominator is 0.
See Technical Notes.Table Printing Tips
							
					
							Last Reviewed:  November 29, 2022						Source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
					Facebook
        Twitter
        LinkedIn
        Syndicate homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue